Medpace Holdings, Inc.
Health
Performance
4.3
Risk
Sell
Buy
Curious about the Scores? Learn more.

Medpace Holdings, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

09.12.2025
Max level achieved. Once more ahead of all the rest.
26.08.2025
Signs of control returning. Still shaky, but not chaos.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.

Medpace Holdings, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Medpace Holdings, Inc. do? Business model and key facts

Get the full picture of Medpace Holdings, Inc.: what it builds, where it operates, and how it makes money.

Medpace Holdings, Inc. Profile

Sector: Healthcare

Industry: Medical - Diagnostics & Research

Employees (FY): 5900

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

shop
Company facts
August James Troendle
CEO
5900
Employees worldwide
shop
Performance
84.36%
Last 12 months
337.09%
Last 5 years
shop
Growth
$2,11B
Revenue year
$404,39M
Net income
shop
Valuation
$17,41B
Market Cap
25.43
Price/Earnings Ratio

Stocks related to Medpace Holdings, Inc.

Selected based on industry alignment and relative market positioning.

EXAS
Exact Sciences Corporation
102.34
+0.08%
6.8
Sell
Buy
Exact Sciences Corporation
DGX
Quest Diagnostics Incorporated
190.26
+1.87%
2.1
Sell
Buy
Quest Diagnostics Incorporated
ILMN
Illumina, Inc.
145.30
+0.92%
6.0
Sell
Buy
Illumina, Inc.
ICLR
ICON Public Limited Company
182.56
-1.20%
5.3
Sell
Buy
ICON Public Limited Company
GH
Guardant Health, Inc.
111.98
+3.11%
7.5
Sell
Buy
Guardant Health, Inc.

Medpace Holdings, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.